Figure 2. [Historical events and the development of anti-obesity medications in the past 100 years.]. - Endotext - NCBI Bookshelf

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.

Cover of Endotext

Endotext [Internet].

Figure 2. . Historical events and the development of anti-obesity medications in the past 100 years.

Figure 2.

Historical events and the development of anti-obesity medications in the past 100 years.

From: An Historical Review of Steps and Missteps in the Discovery of Anti-Obesity Drugs

Copyright © 2000-2024, MDText.com, Inc.

This electronic version has been made freely available under a Creative Commons (CC-BY-NC-ND) license. A copy of the license can be viewed at http://creativecommons.org/licenses/by-nc-nd/2.0/.

Views

Cite this Page
Bray GA, Purnell JQ. An Historical Review of Steps and Missteps in the Discovery of Anti-Obesity Drugs. [Updated 2022 Jul 10]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Figure 2. [Historical events and the development of anti-obesity medications in the past 100 years.].

Related information

PMC
PubMed Central citations
PubMed
Links to PubMed

Similar articles in PubMed

Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.[Cochrane Database Syst Rev. 2022]
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, et al. Cochrane Database Syst Rev. 2022 Feb 1; 2(2022). Epub 2022 Feb 1.
Review Existing and Emerging Molecular Targets for the Pharmacotherapy of Obesity.[Endotext. 2000]
Review Existing and Emerging Molecular Targets for the Pharmacotherapy of Obesity.
Glykofrydi S, Kokkinos A, Barber TM, Mastorakos G, Valsamakis G. Endotext. 2000
The future of Cochrane Neonatal.[Early Hum Dev. 2020]
The future of Cochrane Neonatal.
Soll RF, Ovelman C, McGuire W. Early Hum Dev. 2020 Nov; 150:105191. Epub 2020 Sep 12.
Review Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.[Pharmacol Rev. 2018]
Review Anti-Obesity Therapy: from Rainbow Pills to Polyagonists.
Müller TD, Clemmensen C, Finan B, DiMarchi RD, Tschöp MH. Pharmacol Rev. 2018 Oct; 70(4):712-746.
Review Tuberculosis.[Major Infectious Diseases. 2017]
Review Tuberculosis.
Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, et al. Major Infectious Diseases. 2017 Nov 3

See reviews...See all...

Recent Activity

Clear Turn Off Turn On

Figure 2. [Historical events and the development of anti-obesity medications in ...
Figure 2. [Historical events and the development of anti-obesity medications in the past 100 years.]. - Endotext

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on